Skip to main content
. 2015 Sep 11;6(31):31702–31720. doi: 10.18632/oncotarget.5165

Figure 8. In silico analysis of OS and DFS in EC patients.

Figure 8

The Kaplan-Meier disease-free survival (DFS) of uterine corpus endometrioid carcinoma patients (n = 333) from a dataset in The Cancer Genome Atlas stratified by A. KDM4B and B. KDM4A expression. C. OncoPrint of AR, KDM4B, KDM4A, c-myc pathway alterations in EC. Genomic alteration provides an overview of genomic alterations (legend) in particular genes (rows) affecting particular individual sample (columns). The Kaplan-Meier D. overall survival (OS) and E. DFS of uterine corpus endometrioid carcinoma patients from a dataset in The Cancer Genome Atlas stratified by AR, KDM4B, KDM4A, and c-myc alteration.